English 
Español 
français 
العربية Search
Search
Linagliptin is a novel, highly effective and selective DPP-4 inhibitor for the treatment of type 2 diabetes. Linagliptin is an oral, highly selective inhibitor of dipeptidyl peptidase-4 and is the first agent of its class to be eliminated predominantly via a nonrenal route. Linagliptin is indicated for once daily use for the treatment of adults with type 2 diabetes mellitus.
| Items | Specification | Result |
Assay | ≥98.5% | 99.77% |
Appearance | White to light yellow powder | Light yellow powder |
| Loss on drying | ≤0.5% | 0.38% |
| Residue on drying | ≤0.1% | 0.07% |
| Single impurity | ≤0.5% | 0.08% |
| Total impurity | ≤1.5% | 0.23% |
| Product parameters | |
| Cas number: | 668270-12-0 |
| Appearance: | White to light yellow powder |
| Purity: | 98.5%min |
| Package details: | 1kg/bag with foil bag;25kg/drum |
| Brand: | Fortunachem |
Guaranteed the purity
High quality & competitive price
Quality control
Fast feedback
Prompt shipment
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
